Navigation Links
BREATHE Lung Cancer Conference, Nov. 30, Attracts World Renowned Physicians and Speakers
Date:11/5/2007

Conference for medical staff, patients and patient advocates

DETROIT, Nov. 5 /PRNewswire-USNewswire/ -- Lung cancer remains the leading cause of cancer death in the United States. More than 60 percent of lung cancer patients have never smoked or quit smoking decades ago. About 70 percent of patients are diagnosed at a late stage and only 15 percent will be alive within five years.

The Barbara Ann Karmanos Cancer Institute and the American Lung Association of Michigan find these statistics alarming and unacceptable. That's why on Friday, Nov. 30, during National Lung Cancer Awareness Month, both organizations will host BREATHE 2007 Lung Cancer Medical and Advocacy Conference. The all-day conference will bring experts together as well as patients and patient advocates to network and learn more about lung cancer advances both in treatment and in advocacy. Medical sessions will be geared toward physicians, nurses and other medical personnel. Advocacy sessions will target patients and those affected by lung cancer who want to make a difference, advance the knowledge of this disease and advocate for more research funding to support early detection for lung cancer.

WHAT: BREATHE 2007 Lung Cancer Medical and Advocacy Conference

WHEN: Friday, Nov. 30

7 a.m. Registration. Conference 8 a.m. - 3:30 p.m.

WHERE: The Ritz-Carlton Dearborn

300 Town Center Dr., Dearborn, Michigan

WHO: Keynote speaker is Deborah Morosini, MD, sister of the late Dana Reeve and board member of the Lung Cancer Alliance. Other medical experts include: John Finn, MD, Karmanos Cancer Institute; Shirish Gadgeel, MD, Karmanos Cancer Institute; Claudia Henschke, MD, Cornell Medical Center; James Jeff, MD, Mayo Clinic; Bruce Johnson, MD, Harvard Medical School; Gregory P. Kalemkerian, MD, University of Michigan Health System; Patricia LoRusso, DO, Karmanos Cancer Institute; Harvey Pass, MD, New York University School of Medicine; Kenneth Rosenzweig, MD Memorial Soloan Kettering;

John C. Ruckdeschel, MD, Karmanos Cancer Institute; Manuel Valdivieso, MD, Karmanos Cancer Institute; and Antoinette Wozniak, MD, Karmanos Cancer Institute. Other advocacy experts include: Thomas V. Angott, Sr., survivor; Carol Christner, Karmanos Cancer Institute; Laurie Fenton, Lung Cancer Alliance; Lori Hope, author; Lori Kondas, American Lung Association; Ed Levitt; Mickey Redmond, survivor and Detroit Red Wings Alumni; Judy Stewart, Campaign for Smokefree Air; and Gayle Zinda, author.

COST: $75 for Medical Professionals. CME credits will be offered to physicians, nurses and other health care personnel. $25 for other patients and advocate guests. Lunch included.

HOW TO

REGISTER: Visit http://www.breathelungcancerconference.org or call 248-784-2017.

Some of the sponsors for the conference include: Lilly, (OSI) pharmaceuticals, Novartis, Sanofi Aventis, Accuray, Blue Cross Blue Shield of Michigan and the Lung Cancer Alliance.

About the American Lung Association Michigan

Beginning its second century, the American Lung Association is the leading organization working to prevent lung disease and promote lung health. Lung disease death rates continue to increase while other leading causes of death have declined. The American Lung Association funds vital research on the causes of and treatments for lung disease. With the generous support of the public, the American Lung Association is "Improving life, one breath at a time." For more information about the American Lung Association or to support the work it does, call 1-800-LUNG-USA (1-800-586-4872) or log on to http://www.alam.org.

About the Barbara Ann Karmanos Cancer Institute

The Barbara Ann Karmanos Cancer Institute is one of 39 National Cancer Institute-designated comprehensive cancer centers in the United States. Caring for more than 6,000 new patients annually on a budget of $216 million, conducting more than 700 cancer-specific scientific investigation programs and clinical trials, the Karmanos Cancer Institute is among the nation's best cancer centers. Through the commitment of 1,000 staff, including nearly 300 faculty members, and supported by thousands of volunteer and financial donors, the Institute strives to prevent, detect and eradicate all forms of cancer. John C. Ruckdeschel, M.D., is the Institute's president and chief executive officer. For more information call 1-800-KARMANOS or go to http://www.karmanos.org.


'/>"/>
SOURCE Barbara Ann Karmanos Cancer Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Accordions Breathe Easier Since Smoking Ban
2. Hundreds to Gather for Rally in Celebration of Right to Breathe Clean Air
3. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
4. Survival differences by race most apparent in advanced stages of breast cancer
5. MRI finds breast cancer before it becomes dangerous
6. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
7. Pathway links inflammation, angiogenesis and breast cancer
8. Radiologists encouraged to look beyond cancer for clinically unseen diseases
9. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
10. Immune deficiency linked to a type of eye cancer
11. Drop in breast cancer incidence linked to hormone use, not mammograms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: